| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8787072 | European Journal of Surgical Oncology (EJSO) | 2017 | 9 Pages |
Abstract
CA19-9/PCI ratio is an independent prognostic factor for overall survival in patients with low-grade PMP undergoing CRS and IPC. By accounting for both tumour activity and tumour volume simultaneously, this novel index behaves as a surrogate of tumour biology and provides a useful adjunct for decisions regarding treatment allocation in this patient group.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
Mathew A. Kozman, Oliver M. Fisher, Bree-Anne J. Rebolledo, Sarah J. Valle, Nayef Alzahrani, Winston Liauw, David L. Morris,